“…These compounds engendered primarily saline-lever responding up to doses that either significantly reduced response rates or induced untoward side effects (e.g., convulsions). We are not aware of any other studies that have administered these particular opioid receptor agonists to ethanol discriminating subjects, however, we selected these compounds based on their known selectivity and/or efficacy profiles at mu and/or delta opioid receptors (e.g., fentanyl: mu opioid receptor full agonist, ~ 100- to 250-fold selective for mu vs. delta, Emmerson et al, 1994; Jagerovic et al, 2002; buprenorphine: mu opioid receptor partial agonist, ~ 3- to 15-fold selective for mu vs. delta, and kappa opioid receptor antagonist, Rennison et al, 2007; Spagnolo et al, 2008; SNC 80: delta opioid receptor full agonist, ~ 800- to 900-fold selective for delta vs. mu, Knapp et al, 1996; Codd et al, 2009; SNC 162: partial agonist, > 1000-fold selective for delta vs. mu, Knapp et al, 1996). Our results, however, are in general concordance with other studies reporting a lack of substitution of the mu opioid receptor agonist morphine for the discriminative stimulus effects of ethanol in monkeys and rats (Winter, 1975; York and Bush, 1982; Bowen et al, 1997; Kosten et al, 1999; Platt et al, 2005).…”